Ms. Caperelli joined Ardelyx Inc in March 2026 as SVP, Investor Relations and Corporate Communication. Ms. Caperelli has more than 20 years of demonstrated experience in leading investor communication strategies for publicly traded biotechnology companies. Prior to joining Arbutus, Lisa oversaw investor relations at Harmony Biosciences, where she assisted the company in its IPO and prepared the investment community for the companies launch of its first FDA approved product. Throughout her career, Ms. Caperelli held roles of increased responsibility in investor relations and corporate communications with several small- to mid-cap biotech companies at various stages of development including Marinus Pharmaceuticals, Advaxis, Inc., PolyMedix and Windtree Therapeutics, Inc. (formerly Discovery Labs). In these roles, Ms. Caperelli has been instrumental in providing strategic guidance, securing capital through various types of financings, and concisely communicating the company’s strategy, growth opportunities and business initiatives to key stakeholders.
Ms. Caperelli holds a Bachelor of Science in Business Administration from Delaware Valley University. She is a board member of NIRI: The Association for Investor Relations, immediate past president of the NIRI Philadelphia Chapter and a member of the Delaware Valley University President’s Advisory Council.